Jacobio Pharmaceuticals Group (1167.HK) Earnings Analysis
Jacobio Pharmaceuticals Group (1167.HK) next reports earnings on 2026-08-28, consensus EPS 0.01155 HKD. Last quarter (2026-03-10) it missed with EPS -0.12242 HKD vs -0.01113 HKD est (-999.9%). It has beaten estimates in 1/3 recent quarters (33%). Trailing P/E -23.43.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 1167.HK next report earnings?
| Next earnings date | 2026-08-28 |
|---|---|
| Consensus EPS estimate | 0.01155 HKD |
| Revenue estimate | 0.75B |
1167.HK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-10 | -0.12242 HKD | -0.01113 HKD | -999.9% | Miss |
| 2025-03-19 | 0.01836 HKD | 0.05322 HKD | -65.5% | Miss |
| 2024-08-30 | -0.23375 HKD | -0.2901 HKD | +19.4% | Beat |
Beat rate: 1/3 (33%) over reported quarters with consensus data.
1167.HK valuation and analyst view
| Trailing P/E | -23.43 |
|---|---|
| Trailing EPS | -0.18652 HKD |
| Price / book | 4.38 |
| Dividend yield | 0.00% |
| Market cap | 4.19B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Jacobio Pharmaceuticals Group (1167.HK)'s next earnings date?
Jacobio Pharmaceuticals Group is next scheduled to report on 2026-08-28, with a consensus EPS estimate of 0.01155 HKD and revenue estimate of 0.75B.
Did 1167.HK beat earnings last quarter?
In its 2026-03-10 report, 1167.HK posted EPS of -0.12242 HKD versus a -0.01113 HKD estimate — a miss of 999.9%.
What is 1167.HK's earnings track record?
Over the last 3 reported quarters with consensus data, 1167.HK beat estimates 1 times (33%).
What is 1167.HK's current P/E ratio and EPS?
1167.HK trades at a trailing P/E of -23.43 on trailing EPS of -0.18652392757908212 HKD.
What do analysts rate 1167.HK?
1167.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.